LEADER 03137nam 22005175 450 001 9910369948503321 005 20200705035654.0 010 $a3-030-25610-3 024 7 $a10.1007/978-3-030-25610-4 035 $a(CKB)4100000009678353 035 $a(MiAaPQ)EBC5968653 035 $a(DE-He213)978-3-030-25610-4 035 $a(PPN)269146237 035 $a(EXLCZ)994100000009678353 100 $a20191023d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNovel Therapeutics for Rare Lymphomas /$fedited by Christopher Dittus 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (259 pages) 311 $a3-030-25609-X 320 $aIncludes bibliographical references and index. 327 $aThe Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom. 330 $aThis comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas. 606 $aOncology   606 $aHematology 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 615 0$aOncology  . 615 0$aHematology. 615 14$aOncology. 615 24$aHematology. 676 $a616.99446059 676 $a616.99446 702 $aDittus$b Christopher$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369948503321 996 $aNovel Therapeutics for Rare Lymphomas$92193412 997 $aUNINA